| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d0d4aaab7042ef967103d8c9cf7d505c |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0021
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-2086
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate |
2018-06-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_75aa3c2d40712622323f0be0ff44b3b0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c6e6a969725c0628ab51644c39d30a7f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b19b7e84d01a86f75cda5bcf645734d7 |
| publicationDate |
2018-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2018236890-A1 |
| titleOfInvention |
COMBINED THERAPY WITH NK-92 CELLS AND IL-15 AGONIST |
| abstract |
The present invention provides methods of treating Merkel cell carcinoma. The methods include selecting a subject having a Merkel cell carcinoma and administering thereto a therapeutically effective amount of NK-92 cells and a therapeutically effective amount of an IL-15 agonist. the administration treating Merkel cell carcinoma in said subject. |
| priorityDate |
2017-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |